Skip to main content

Table 1 Descriptive analysis for questionnaire data

From: The effects of the COVID-19 pandemic on patients with lysosomal storage disorders in Israel

Questionnaire data

No. ( %)

Total

48 (100)

Males (%)

29 (60)

No. (%) of patients treated with ERT* or other parenteral

28 (58.3)

No.(%) of patients that missed ERT or parenteral treatments during COVID-19 pandemic

7 (25)

No. (%) of patients that were under the age 18 years during COVId-19 pandemic

46 (95)

No. (%) of patients reporting mood deterioration during COVID-19 pandemic

7 (14.6)

No. (%) of patients reporting increased aggressiveness during COVID-19 pandemic

7 (14.6)

No. (%) of patients reporting cognitive function decline during COVID-19 pandemic

8 (16.7)

No. (%) of patients reporting motor function decline during COVID-19 pandemic

11 (23.9)

  1. *ERT enzyme replacement therapy